This means a doctor takes tissue or an organ from your own body. They move it from one place to another place in your body. For example, they might take skin from your arm and put it on your leg.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
An autologous transplant uses a person's own cells or tissue rather than a donor's. The term can describe moving tissue from one part of the body to another, but in everyday medicine it almost always means an autologous stem cell transplant, sometimes called an autologous bone marrow transplant or an "auto transplant." That is the procedure this page describes. Blood-forming stem cells live in the bone marrow, the spongy tissue inside large bones. They produce red blood cells, which carry oxygen, white blood cells, which fight infection, and platelets, which help blood clot. Some cancers can be treated with chemotherapy at doses high enough to destroy the marrow along with the disease. An autologous transplant makes those doses possible: your own stem cells are collected and frozen first, the high-dose treatment is given, and then the stored cells are returned to rebuild the marrow. The high-dose treatment does the work against the cancer; the returned cells are the rescue that lets the body make blood again. It is used mainly for multiple myeloma, certain lymphomas and some leukemias, and sometimes for other cancers such as testicular cancer and, in children, neuroblastoma. Some specialized centers also use it for selected autoimmune diseases, including systemic sclerosis and multiple sclerosis. Compared with an allogeneic transplant, which uses donor cells, an autologous transplant needs no donor match and cannot cause graft-versus-host disease, in which donor immune cells attack the body. The trade-off is that there is no donor immune system to help destroy leftover cancer, and a small number of cancer cells can be collected and returned along with the stem cells. In myeloma, large trials found that adding a transplant to modern drug combinations kept the disease under control longer (in one trial, a median of 50 months before it progressed, versus 36 months without transplant), but did not show that people lived longer overall. Whether and when to have one is therefore a genuine discussion. Overall fitness and organ function usually matter more than age alone.
Preparation begins weeks ahead with tests of whether your body can handle high-dose treatment. These usually include blood tests (including screening for viruses such as hepatitis B and HIV), heart tests such as an echocardiogram, lung function tests, and often scans or a bone marrow biopsy to check the disease. Many centers add a dental check, a meeting with a social worker and a review of insurance coverage, because the costs are high. Most people have a central venous catheter placed, a thin tube that sits in a large vein in the chest, usually as an outpatient procedure with local anesthesia. It is used to collect stem cells, give chemotherapy, fluids and transfusions, and draw blood, and it typically stays in until blood counts recover. The stem cells are then collected. For several days you receive injections of a medicine that moves stem cells out of the marrow and into the bloodstream. Your blood is then passed through an apheresis machine, which separates out the stem cells and returns the rest of your blood. Collection can take several days and sometimes has to be repeated. The cells are frozen and stored until the transplant. Practical planning matters as much as the medical tests. Centers require an adult caregiver who can be closely involved throughout, often all day during the first weeks, and some ask you to stay within a set distance of the hospital. If you might want children in the future, ask about banking sperm or eggs before any treatment starts, because high-dose chemotherapy often causes infertility. Arranging time off work, childcare, transportation and an advance directive ahead of time makes the months that follow easier.
The transplant itself happens in two stages. The first is conditioning: high-dose chemotherapy given through the catheter or as pills, usually over a few days to about a week and a half, occasionally with radiation to the whole body. In myeloma the usual drug is high-dose melphalan, a chemotherapy medicine. This stage treats the disease and wipes out the remaining marrow, so once it starts the transplant must be completed; without the stored cells the marrow could not recover. After a day or two of rest comes "day zero," when the thawed stem cells are infused through the catheter, much like a blood transfusion. You are awake, and it does not hurt. Each bag takes about 30 minutes, and there may be several. You may get medicine beforehand to reduce reactions to the preservative used for freezing. That preservative leaves a strong taste and body odor, often compared to garlic or creamed corn, that fades over a few days. Fever, chills or shortness of breath during the infusion are uncommon, usually mild, and treated on the spot. Depending on the center, this may take place in a hospital unit designed to limit infection, or largely as an outpatient with daily clinic visits.
The hardest stretch is usually the first two weeks after the infusion, while the returned stem cells settle into the marrow and begin producing new blood cells, a process called engraftment. Blood counts fall to their lowest point, and mouth sores, nausea, diarrhea, poor appetite, hair loss and deep fatigue are common. Medicines to prevent bacterial, viral and fungal infections, and transfusions of red blood cells and platelets, are routine. For autologous transplants the hospital stay, or the period of daily clinic visits, is typically about two weeks, longer if infection or slow recovery occurs. Discharge generally waits until counts are rising, fever has settled, and you can eat, drink and take medicines by mouth. At home, tiredness lasts weeks to months. Blood counts can return to normal well before the immune system does, which takes several months after an autologous transplant, so infection precautions continue: careful hand washing, avoiding people who are sick, garden soil, litter boxes and certain raw foods, as your center advises. Childhood vaccinations are repeated later on a schedule the team provides. Visits are frequent at first and space out as recovery goes well. Many people go on to further treatment, such as maintenance therapy in myeloma, and long-term follow-up continues for years. While counts are low, fever is often the first and sometimes the only sign of a serious infection. Call the transplant team right away, at any hour, for a fever, chills or any new shortness of breath or change in breathing. Tell the team about easy bruising, nosebleeds or bleeding gums as well. Make sure you have the after-hours number before you leave the hospital.
Most of the danger comes from the high-dose chemotherapy and the weeks of very low blood counts that follow, not from the infusion itself. Serious infection is the main early risk, and bleeding can occur while platelets are low. Mouth and throat sores can make eating painful for a time. Less often, the lungs, heart, liver or kidneys are damaged, and occasionally the returned cells fail to engraft, which may be treated with a backup dose of stored cells if any are available. Complications can be life-threatening, although autologous transplants avoid graft-versus-host disease, one of the most serious problems of donor transplants. Later effects can include infertility or early menopause, cataracts, hormone changes such as an underactive thyroid, and lasting effects on the lungs, heart or kidneys. Years later there is a small risk of a second cancer, including leukemia or myelodysplastic syndrome (a disorder in which the marrow makes faulty blood cells). The original disease can also come back, which is why a transplant is often one part of a longer treatment plan rather than the end of it. The experience also takes an emotional toll. Anxiety, depression, trouble concentrating and strain on relationships and work are common for both patients and caregivers, and transplant teams expect to talk about them.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Autologous Transplantation, what to expect, or ask the community a question.